Tocilizumab treatments in patients with noninfectious uveitis demonstrated high rates of success at 1 year follow ups.

Sunvozertinib has shown promising results in patients with non–small cell lung cancer with an EGFR exon 20 insertion mutation ...

The global peripheral intravenous catheter market is projected to experience robust growth over the next decade, with market size expected to exceed USD 13,006.1 million by 2034, up from USD 6,489.3 ...

Medically reviewed by Qin Rao, MD Crohn's disease (CD) is an inflammatory bowel disease (IBD) that affects more than half a ...

[77] Bolus doses in the range of 625 mg to 2.5 g (12.5–50 mg/kg) have been fatal. Premixed injection solutions are available and may help reduce dosage errors. For patients on diuretic therapy ...

ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, today announced the nationwide rollout of its ...

Allakos shifted focus to AK006 in 2024 after lirentelimab's failure in phase 2 trials for atopic dermatitis and CSU. Read why ...

Preclinical data demonstrated durable immune responses and tumor growth inhibition with Mural's IL-18 variants, reinforcing ...

Achieved Third Quarter 2024 Net Product Sales of $7.0 Million ~~ Increasing Momentum and Successful Reimbursement in the Adolescent and Young ...

AngioDynamics, a medical device company - manufactures port catheters widely used for patients needing regular IV treatments or medications.However, recent reports have raised concerns regarding certa ...

The Company has one approved product in the United States, OLINVYK ® (oliceridine) injection, indicated in adults for the management of acute pain severe enough to require an intravenous opioid ...

The Adrenaverse platform is a relatively new platform by Aquestive. This platform is essentially the 'secret-sauce' ...